From d30a85d89728828f11d7a3ecc370ddc1ef688401 Mon Sep 17 00:00:00 2001 From: Borja Robert Date: Mon, 11 Mar 2024 10:34:02 +0100 Subject: [PATCH] Auto saved by Logseq --- pages/STOP2030___Web___Posts.md | 2 +- 1 file changed, 1 insertion(+), 1 deletion(-) diff --git a/pages/STOP2030___Web___Posts.md b/pages/STOP2030___Web___Posts.md index fbdcc8bf..e9398142 100644 --- a/pages/STOP2030___Web___Posts.md +++ b/pages/STOP2030___Web___Posts.md @@ -9,6 +9,6 @@ The general objectives of the REALISE study are to validate the benefits of the FDC through this pragmatic trial in a context of mass drug administration (MDA) programme to evaluate the safety as a primary endpoint and effectiveness profile as a secondary endpoint, in a large population of school-aged children. - The clinical trial will have two arms, randomized by school. One will be administered the fixed-dose coformulation of albendazole and ivermectin while the other, acting as an active control group, will receive + The clinical trial will have two arms, randomized by school. One will be administered a single dose of the fixed-dose coformulation tablet, while the other, acting as an active control group, will receive #+END_VERSE \ No newline at end of file